Share this article
Share this article
DUBLIN, Feb. 8, 2021 /PRNewswire/ Nemysis Limited, the Dublin based pharmaceutical and healthcare company, focused on Iron Deficiency/Anemia and Gluten Sensitivity, today announced that the South Africa Patent and Trademark Office has issued S.A. Patent No.ZA201802192, with claims of Methods for Producing Carboxylate Ligand Modified Ferric Iron Hydroxide Colloids and Related Compositions and Uses, directed to the use of oral iron supplementation. This is an advancement in our efforts to broaden our global patent estate for IHAT, said Danilo Casadei-Massari, Chairman and Chief Executive Officer of Nemysis. To date, our intellectual property portfolio spans multiple patents and patent applications in the U.S., EU, and numerous additional countries.